Evidence map›Paper›PMID 33326662›Full record

ArticleEuropean journal of pain (London, England)2021

Widespread myofascial dysfunction and sensitisation in women with endometriosis-associated chronic pelvic pain: A cross-sectional study.

Vy T Phan, Pamela Stratton, Hannah K Tandon, Ninet Sinaii, Jacqueline V Aredo, Barbara I Karp, Melissa A Merideth, Jay P Shah

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in European journal of pain (London, England), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01553201 (The Effectiveness of Botulinum Toxin on Persistent Pelvic Pain in Women With Endometriosis), which is not on this map. Cited by 36 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 1 pooled it
5.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01553201 phase1 / phase2completednot on this map

The Effectiveness of Botulinum Toxin on Persistent Pelvic Pain in Women With Endometriosis

TypeinterventionalSponsorNational Institute of Neurological Disorders and Stroke (NINDS)Ran2014 to 2019Enrolled30ConditionsEndometriosis, Chronic Pelvic Pain, Pelvic Muscle Spasm, Quality of LifeArmsBotulinum toxin (BoNT), Placebo
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 1 synthesis or guideline pooled it, 54 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Trial
  4. Altered Blood Pressure Reflexes in Women With Endometriosis.Hypertension (Dallas, Tex. : 1979) · 2025
    Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Review
  16. Identifying and characterizing clinical subgroups in individuals with endometriosis.Frontiers in pain research (Lausanne, Switzerland) · 2025
    Article
  17. Article
  18. Nociplastic Pain in Endometriosis: A Scoping Review.Journal of clinical medicine · 2024
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Vy T PhanRehabilitation Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-8654-1013
Pamela StrattonOffice of the Clinical Director, Intramural Research Program, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-8700-7197
Hannah K TandonRehabilitation Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-2522-7979
Ninet SinaiiBiostatistics & Clinical Epidemiology Service, Intramural Research Program, Clinical Center, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0003-4045-1386
Jacqueline V AredoStanford University School of Medicine, Stanford, CA, USA.ORCID 0000-0003-0559-3565
Barbara I KarpOffice of the Clinical Director, Intramural Research Program, National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-4604-0142
Melissa A MeridethOffice of the Clinical Director, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0003-0487-2685
Jay P ShahRehabilitation Medicine Department, Clinical Center, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-0086-1690
National Institutes of Health Clinical Center · USNational Institutes of Health · USStanford University · US

Funding

The effectiveness of Botulinum toxin on persistent pelvic pain in women with endometriosisZIANS003159 · NINDS · NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE · PI STRATTON, PAMELA · 2017 to 2025
$643k
Intramural NIH HHS ZIA NS003159
6 · The paper itself

Abstract

backgroundChronic pelvic pain persists in some women with endometriosis even after lesion removal and optimized hormonal treatment.

objectiveCharacterize the presence and distribution of pain, myofascial dysfunction and sensitisation beyond the pelvis in women with endometriosis-associated chronic pelvic pain.

methodsCross-sectional study of 30 women prior to participation in a clinical trial. Evaluation included pain-focused abdominopelvic gynaecologic examination with the identification of pelvic floor muscle spasm. Neuro-musculoskeletal examination assessed paraspinal allodynia and hyperalgesia bilaterally and myofascial trigger points in 13 paired muscles. Pressure-pain thresholds were measured over interspinous ligaments and trigger points. Women completed the body territories element of the Body Pain Index.

resultsAll women had a pelvic floor muscle spasm that they self-identified as a major focus of pain. Twenty of 30 women described their pelvic pain as focal. However, all demonstrated widespread myofascial dysfunction with low pressure-pain thresholds and trigger points in over two-thirds of 26 assessed regions. Widespread spinal segmental sensitisation was present in 17/30, thoracic in 21/30 and lumbosacral/pelvic in 18/30. Cervical sensitisation manifested as low pressure-pain thresholds with 23/30 also reporting recurrent, severe headaches and 21/30 experiencing orofacial pain. Those reporting diffuse pelvic pain were more likely to have widespread (p = .024) and lumbosacral/pelvic (p = .036) sensitisation and report over 10 painful body areas (p = .009).

conclusionsWomen with endometriosis-associated chronic pelvic pain often have myofascial dysfunction and sensitisation beyond the pelvic region that may be initiated or maintained by on-going pelvic floor spasm. These myofascial and nervous system manifestations warrant consideration when managing pain in this population. Clinicaltrials.gov identifier: NCT01553201. SIGNIFICANCE: Women with endometriosis often have pelvic pain persisting after surgery despite hormonal therapies and these women have regional pelvic sensitisation and myofascial dysfunction. Pelvic floor muscle spasm is a major pain focus in this population. Sensitisation and myofascial dysfunction are widespread, beyond the pelvic region. On-going pelvic floor spasm may initiate or maintain sensitisation. Myofascial/sensitisation manifestations warrant consideration when managing pain in this population.

Indexed as

Chronic PainEndometriosisMyofascial Pain SyndromesCross-Sectional StudiesFemaleHumansPelvic Pain

Identifiers

PMID33326662
PMCPMC7979491
OpenAlexW3111890146

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.